🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

En route to #ASCO24 for the first time! Come and check out our poster on Saturday at board #355 1:30pm Hall A meetings.asco.org/abstracts-pres…

Great to see the NHS cancer vaccine launch pad being applauded from across the pond in Chicago at #ASCO24 👏🏻

Promising data from Iovance Biotherapeutics COM202 (1st line TIL+pembro in MM). Small numbers (n=23) but ORR 65% and CR in 30%. Will be important to see how data from the larger TILVANCE study compares.

A pleasure presenting our novel granulocyte ratio (NEBR) melanoma data at #ASCO24. Lots of interesting discussion! Dr Sophia Wong Andrew Furness The Royal Marsden NHS Foundation Trust

OBX-115 ORR 44% with 2 CRs! 100% DCR! This is SUPER exciting prelim efficacy and safety signal. Larger phase 1–>2 ongoing with planned expansion to NSCLC ongoing now. Available at Stanford Cancer Institute!!! #melanoma #ASCO24 OncoAlert

Interim analysis for IGNYTE-ESO substudy 2- NYESO1 targeting TCR therapy for MRCLS and synovial sarcoma. ORR 40%, primary analysis expected end of 2024. Has been great being able to contribute to this important study at The Royal Marsden NHS Foundation Trust #ASCO24

Exciting news to hear that the first genetically engineered solid tumour cellular therapy has just been granted accelerated approval by the U.S. FDA! adaptimmune.com/investors-and-…

Any footballers coming to ESMO and wanting to play in the UK team please DM me! ⚽️🇬🇧⚽️🇬🇧

A great evening thank you Daniel Castellano for organising. Congrats to team Ireland for winning against us on penalties in the final. 🇮🇪🇬🇧#ESMO24 Duncan Gilbert Adam Hexter Mark Baxter Zayd Tippu

What a pleasure to be giving a talk with this panel on novel #immunotherapy #bispecifics #bites #cancervaccines #celltherapy with Fernanda G. Herrera udaibanerji @ElenaGarralda Tim Yap. Thank you for the opportunity! #ESMO24

Great catching up with Jon Lim, MRCP PhD and Dr Sophia Wong to discuss all things cellular therapy at #ESMO2024

Great IO and cell therapy fellowship opportunity in Manchester! ⬇️⬇️

Delighted to share our new paper reviewing toxicity management strategies for solid tumour cell therapy in ESMO IOTECH . A great team effort from Dr Sophia Wong Jon Lim, MRCP PhD Andrew Furness ! sciencedirect.com/science/articl…

Toxicity management strategies for solid tumour cell therapy - Dr Max Julvé oncodaily.com/url/218317 ESMO IOTECH Dr Sophia Wong Jon Lim, MRCP PhD Andrew Furness #Cancer #SolidTumors #ImmuneOnc #IO #ImmunoOncology #MedEd #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Congrats Zayd Tippu!! Future RCC royalty 👑